Reuters Guardian Pharmacy, which provides pharmacy services to longterm healthcare facilities, raised 112 million in its U.S. initial public offering on Wednesday, valuing the company at 869.3 million.

The Atlanta, Georgiabased firm priced its offering of 8 million shares of Class A common stock at 14 apiece, the lowend of its targeted range of 14 to 16 each.

The U.S. market for fresh listings is seeing a recovery in investor appetite, boosted by expectations of monetary policy easing by the country39;s Federal Reserve and market optimism for a soft landing.

Investors have been selective in backing companies, with those burning cash as least favored, after a twoyear IPO market downturn that saw poor performance from a raft of recently public highprofile firms.

Guardian Pharmacy, which was founded in 2004, offers a suite of technologyenabled services designed to help residents of longterm health care facilities. It was operating 50 pharmacies serving roughly 174,000 residents, as of June 30.

For the fullyear 2023, Guardian Pharmacy39;s revenue rose to 1.05 billion, compared with 908.9 million a year earlier.

More than twothirds of the company39;s annual revenue over the past three years has been generated from residents in assisted living facilities, behavioral health facilities and group homes, the company said in a regulatory filing.

Guardian Pharmacy said the remainder of the revenue is generated from residents of skilled nursing facilities.

It turned a net…